Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards

Affiliations

• ¹ European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium. Electronic address: andrew.bottomley@eortc.be.
• ² European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
• ³ Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
• ⁴ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
• ⁵ Methodology and Quality of Life Unit in Cancer, INSERM U1098, Universitary Hospital of Besançon, Besançon, France.
• ⁶ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, UK.
• ⁷ Genentech, a member of the Roche group, San Francisco, CA, USA.
• ⁸ Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁹ Adelphi Values, Bollington, Cheshire, UK.
• ¹⁰ Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA.
• ¹¹ Office of Health Economics, London, UK.
• ¹² Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
• ¹³ School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
• ¹⁴ Obstetrics and Gynecology, Medical University Graz, Graz, Austria.
• ¹⁵ Boehringer-Ingelheim, Frankfurt, Germany.
• ¹⁶ Department of Public Health and Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
• ¹⁷ Methodology and Biostatistics department, University Hospital of Angers UNAM, Angers, France.
• ¹⁸ School of Psychology and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
• ¹⁹ Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MA, USA.
• ²⁰ Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
• ²¹ College of Pharmacy, University of Arizona, Tucson, AZ, USA.
• ²² Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
• ²³ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ²⁴ Medicines and Healthcare products Regulatory Agency, London, UK.
• ²⁵ International Brain Tumour Alliance, Surrey, UK.
• ²⁶ Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium.
• ²⁷ Health Sciences, University of Aveiro, Aveiro, Portugal; Lenitudes Medical Center & Research, Santa Maria da Feira, Portugal.
• ²⁸ European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Epidemiological Methods Section, Stockholm, Sweden.
• ²⁹ VU University Medical Center, Department of Neurology & Brain Tumor Center, Amsterdam, The Netherlands.
• ³⁰ Institute for Quality and Efficiency in Health Care, Cologne, Germany.
• ³¹ Health Canada, Ottawa, ON, Canada.
• ³² Leiden University Medical Center/Medical Center Haaglanden, Leiden/The Hague, Netherlands.
• ³³ Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK.